Topical Steroid Withdrawal in Atopic Dermatitis: Patient-reported Characterization from a Swedish Social Media Questionnaire
DOI:
https://doi.org/10.2340/actadv.v105.40187Keywords:
Atopic Dermatitis, Red Skin Syndrome, Topical Steroid Addiction, Topical Steroid Withdrawal, Topical Steroid Withdrawal SyndromeAbstract
Topical steroid withdrawal (TSW) is described as an adverse reaction to topical glucocorticoids (TGCs). A pathophysiological mechanism has not been identified. There are no diagnostic criteria. The aim was to describe patient-reported characteristics of TSW in atopic dermatitis (AD). An observational cross-sectional study was performed by posting a questionnaire for participants, aged ≥18 years, reporting both AD and TSW, in a Swedish TSW-themed Facebook group during 4 weeks in 2023. The questionnaire was accessed by 98 participants, with 82 completing it. Most were female (95%), 18–39 years old (74%), self-diagnosed with TSW (84%), and reported current symptoms of AD and TSW. They defined TSW as dependency on TGCs and adverse reactions to their use. Erythema, desquamation, dryness, and oozing affecting the face, neck, and upper extremities were the most reported signs. Pruritus, sleep disturbance, and signs of anxiety and depression were the most reported symptoms. Recurring episodes of manifestations attributed to TSW were reported by 60%. The personal trigger factor was believed to be TGCs by 93%, and 33% also identified oral glucocorticoids. TGCs were currently used by 21%. Self-reported manifestations of TSW are similar to those of AD but appeared to be distinguishable for the participants and caused considerable morbidity.
Downloads
References
Hajar T, Leshem YA, Hanifin JM, Nedorost ST, Lio PA, Paller AS, et al. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol 2015; 72: 541-549 e542.
https://doi.org/10.1016/j.jaad.2014.11.024 DOI: https://doi.org/10.1016/j.jaad.2014.11.024
Topical Steroid Withdrawal. British Association of Dermatologists, British Dermatological Nursing Group, National Eczema Society, 2024. Available from: https://cdn.bad.org.uk/uploads/2024/02/22095550/Topical-Steroid-Withdrawal-Joint-Statement.pdf.
Bowe S, Masterson S, Murray G, Haugh I. Topical steroid withdrawal through the lens of social media. Clin Exp Dermatol 2022; 47: 1554-1557.
https://doi.org/10.1111/ced.15194 DOI: https://doi.org/10.1111/ced.15194
Nickles MA, Coale AT, Henderson WJA, Brown KE, Morrell DS, Nieman EL. Steroid phobia on social media platforms. Pediatr Dermatol 2023; 40: 479-482.
https://doi.org/10.1111/pde.15269 DOI: https://doi.org/10.1111/pde.15269
Hwang J, Lio PA. Topical corticosteroid withdrawal ('steroid addiction'): an update of a systematic review. J Dermatolog Treat 2022; 33: 1293-1298.
https://doi.org/10.1080/09546634.2021.1882659 DOI: https://doi.org/10.1080/09546634.2021.1882659
Barlow R, Proctor A, Moss C. Topical steroid withdrawal: a survey of UK dermatologists' attitudes. Clin Exp Dermatol 2024; 49: 607-611.
https://doi.org/10.1093/ced/llae045 DOI: https://doi.org/10.1093/ced/llae045
Cotter C, Burton T, Proctor A, Moss C, Flohr C. Topical steroid withdrawal syndrome: time to bridge the gap. Br J Dermatol 2022; 187: 780-781.
https://doi.org/10.1111/bjd.21770 DOI: https://doi.org/10.1111/bjd.21770
Gust P, Jacob SE. The role of delayed-delayed corticosteroid contact dermatitis in topical steroid withdrawal. J Am Acad Dermatol 2016; 75: e167.
https://doi.org/10.1016/j.jaad.2016.05.048 DOI: https://doi.org/10.1016/j.jaad.2016.05.048
O'Connor C, Murphy M. Scratching the surface: a review of online misinformation and conspiracy theories in atopic dermatitis. Clin Exp Dermatol 2021; 46: 1545-1547.
https://doi.org/10.1111/ced.14679 DOI: https://doi.org/10.1111/ced.14679
Finnegan P, Murphy M, O'Connor C. #corticophobia: a review on online misinformation related to topical steroids. Clin Exp Dermatol 2023; 48: 112-115.
https://doi.org/10.1093/ced/llac019 DOI: https://doi.org/10.1093/ced/llac019
Tan SY, Chandran NS, Choi EC. Steroid phobia: Is there a basis? A review of topical steroid safety, addiction and withdrawal. Clin Drug Investig 2021; 41: 835-842.
https://doi.org/10.1007/s40261-021-01072-z DOI: https://doi.org/10.1007/s40261-021-01072-z
Tan S, Phan P, Law JY, Choi E, Chandran NS. Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients. BMJ Open 2022; 12: e060867.
https://doi.org/10.1136/bmjopen-2022-060867 DOI: https://doi.org/10.1136/bmjopen-2022-060867
Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers 2018; 4: 1.
https://doi.org/10.1038/s41572-018-0001-z DOI: https://doi.org/10.1038/s41572-018-0001-z
Waclawski E. How I use it: Survey Monkey. Occup Med (Lond) 2012; 62: 477.
https://doi.org/10.1093/occmed/kqs075 DOI: https://doi.org/10.1093/occmed/kqs075
Alsterholm M, Svedbom A, Anderson CD, Holm Sommar L, Ivert LU, Josefson A, et al. Establishment and utility of SwedAD: a nationwide Swedish registry for patients with atopic dermatitis receiving systemic pharmacotherapy. Acta Derm Venereol 2023; 103: adv7312.
https://doi.org/10.2340/actadv.v103.7312 DOI: https://doi.org/10.2340/actadv.v103.7312
Byrom B, Elash CA, Eremenco S, Bodart S, Muehlhausen W, Platko JV, et al. Measurement comparability of electronic and paper administration of visual analogue scales: a review of published studies. Ther Innov Regul Sci 2022; 56: 394-404.
https://doi.org/10.1007/s43441-022-00376-2 DOI: https://doi.org/10.1007/s43441-022-00376-2
Baltar F, Brunet I. Social research 2.0: virtual snowball sampling method using Facebook. Internet Res 2012; 22: 57-74.
https://doi.org/10.1108/10662241211199960 DOI: https://doi.org/10.1108/10662241211199960
Ferrario B, Stantcheva S. Eliciting people's first-order concerns: text analysis of open-ended survey questions. AEA Papers and Proceedings 2022; 112: 163-169.
https://doi.org/10.1257/pandp.20221071 DOI: https://doi.org/10.1257/pandp.20221071
Hulsen T, de Vlieg J, Alkema W. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 2008; 9: 488.
https://doi.org/10.1186/1471-2164-9-488 DOI: https://doi.org/10.1186/1471-2164-9-488
Whitaker C, Stevelink S, Fear N. The use of Facebook in recruiting participants for health research purposes: a systematic review. J Med Internet Res 2017; 19: e290.
https://doi.org/10.2196/jmir.7071 DOI: https://doi.org/10.2196/jmir.7071
Browne K. Snowball sampling: using social networks to research non‐heterosexual women. Int J Social Research Methodology 2005; 8: 47-60.
https://doi.org/10.1080/1364557032000081663 DOI: https://doi.org/10.1080/1364557032000081663
Sheary B. Steroid withdrawal effects following long-term topical corticosteroid use. Dermatitis 2018; 29: 213-218.
https://doi.org/10.1097/DER.0000000000000387 DOI: https://doi.org/10.1097/DER.0000000000000387
Sheary B, Harris MF. Cessation of long-term topical steroids in adult atopic dermatitis: a prospective cohort study. Dermatitis 2020; 31: 316-320.
https://doi.org/10.1097/DER.0000000000000602 DOI: https://doi.org/10.1097/DER.0000000000000602
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020; 396: 345-360.
https://doi.org/10.1016/S0140-6736(20)31286-1 DOI: https://doi.org/10.1016/S0140-6736(20)31286-1
Arnold KA, Treister AD, Lio PA. Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: a retrospective case series. JAAD Case Rep 2018; 4: 860-862.
https://doi.org/10.1016/j.jdcr.2018.06.012 DOI: https://doi.org/10.1016/j.jdcr.2018.06.012
Barta K, Fonacier LS, Hart M, Lio P, Tullos K, Sheary B, et al. Corticosteroid exposure and cumulative effects in patients with eczema: results from a patient survey. Ann Allergy Asthma Immunol 2023; 130: 93-99 e10.
https://doi.org/10.1016/j.anai.2022.09.031 DOI: https://doi.org/10.1016/j.anai.2022.09.031
Spergel JM, Leung DYM. Topical steroid withdrawal syndrome: should we worry? Ann Allergy Asthma Immunol 2023; 130: 8.
https://doi.org/10.1016/j.anai.2022.09.005 DOI: https://doi.org/10.1016/j.anai.2022.09.005
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Mikael Alsterholm, Maja af Klinteberg, Sophie Vrang, Gunnthorunn Sigurdardottir, MariHelen Sandström Falk, Alexander Shayesteh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
